You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. A Real Time Monitoring System to Measure IOP in Glaucoma

    SBC: ASSENTI, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Assenti LLC is a 10-person start-up company formed out of collaborative research teams from the University of Louisville's Speed School of Engineering and the Department of Ophthalmology & Visual Sciences along with key industry partners. Assenti's enclosed SBIR Phase II application will allow us to continue our significant progress and momentum towards becomin ...

    SBIR Phase II 2006 Department of Health and Human ServicesNational Institutes of Health
  2. STIMULATION-AUGMENTED EXERCISE AND NEUROMOTOR THERAPY

    SBC: CUSTOMKYNETICS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): This project proposes to develop an electrical stimulation augmented exercise device for individuals with incomplete spinal cord injury (iSCI). The device will provide a closed-chain, load bearing lower extremity exercise that has the potential to increase muscle mass, strength, and endurance, and may additionally reverse or slow the rate of loss of bone minera ...

    SBIR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health
  3. Peptidomimetics for Manipulation of Growth Cone Motility and Axon Regeneration

    SBC: ECM BIOSCIENCES            Topic: N/A

    DESCRIPTION (provided by applicant): Thousands of people every year experience long-term or lifelong disabilities in motor, sensory, and cognitive function as result of central nervous system (CNS) injuries. There has been little hope for recovery from these dysfunctions because axons from injured neurons in the brain and spinal cord do not regenerate. A major impediment to regeneration is the for ...

    SBIR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health
  4. Nasal Delivery of Naltrexone for Treatment of Alcoholism

    SBC: INTRANASAL TECHNOLOGY, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Alcohol abuse, dependence, and related societal effects exert a tremendous toll on world-wide and American health and economics. Given this devastating impact, the significant lack of pharmaceutical intervention, even for those patients seeking treatment, is troubling. This phase 1 Small Business Technology Transfer Research (STTR) project will apply novel nasa ...

    STTR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health
  5. NOVEL THERAPY FOR MARIJUANA ADDICTION

    SBC: MURTY PHARMACEUTICALS, INC.            Topic: N/A

    N/A

    SBIR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health
  6. Novel estrogen receptor ligands from plant genomics

    SBC: NAPROGENIX, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Plants produce many types of molecules, such as chalcones flavones and flavonones, that interact with human estrogen receptors (ERs). Some of these may have therapeutic value in different types of hormone-sensitive cancer, but the full capacity of the plant genome to generate such ligands has not been explored. This project uses a functional genomics approach i ...

    STTR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health
  7. Retina Implantation Instrument Kit

    SBC: Ocular Transplantation LLC            Topic: N/A

    DESCRIPTION (provided by applicant): The overall goal of this project is to develop a retina implantation instrument kit that will allow: 1) retinal surgeons to harvest, dissect, and transplant sheets of undifferentiated fetal retinal tissue with its retinal pigment epithelium (RPE) and then transplant these cografts into the subretinal space, 2) other transplant protocols for microchips and RPE/c ...

    SBIR Phase II 2006 Department of Health and Human ServicesNational Institutes of Health
  8. Identification of anti-cariogenic/low-glycemic activity factors from Lo Han Kuo

    SBC: ORACEUTICALS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): While there exist numerous artificial sweeteners that are commercially available, designed to provide zero- or low-calorie artificial alternatives to sucrose/high fructose corn syrup, there remain concerns regarding potential health concerns in the general population or unique subsets of individuals (e.g. phenylketonurics and diabetics). Moreover, altered sugar ...

    STTR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health
  9. Targeting drug-delivery nanoparticles to sites of inflammation

    SBC: POTENTIA PHARMACEUTICALS, INC            Topic: N/A

    DESCRIPTION (provided by applicant): The purpose of this project is to develop a nanoparticle-based drug delivery system for use in the treatment of the exudative form of aged-related macular degeneration (ARMD). ARMD is the leading cause of blindness for individuals over fifty-five years of age that live in the industrialized world. It affects approximately 10 million people in the US and as many ...

    STTR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health
  10. Preventing choroidal neovascularization by long-term transscleral drug delivery

    SBC: POTENTIA PHARMACEUTICALS, INC            Topic: N/A

    DESCRIPTION (provided by applicant): Age-related Macular Degeneration (ARMD) is the leading cause of blindness for individuals over fifty-five years of age that live in the industrialized world. With the introduction of novel anti-angiogenic agents, clinical intervention is currently possible, but only for the wet form of the disease. However, these treatments are severely limited by the fact that ...

    STTR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government